UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO

Endowment

Position in JNJ — Johnson & Johnson

CIK 1019231 AUSTIN, TX

Back to JNJ Full portfolio

Position in JNJ

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$426,161

-$8,224,979 QoQ

Shares Held

1,678

-96.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

#3,847

of 4,664 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in JNJ Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO holds $7,291,310 across 9 Drug Manufacturers - General names. JNJ ranks #4 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PFE	Pfizer Inc	165,020	$3,973,681
2	LLY	ELI LILLY & Co	1,114	$1,336,165
3	NVS	Novartis AG	4,919	$770,905
4	JNJ	Johnson & Johnson This page	1,678	$426,161
5	ABBV	AbbVie Inc.	1,204	$302,974
6	MRK	Merck & Co., Inc.	1,783	$229,115
7	GILD	Gilead Sciences, Inc.	950	$120,023
8	BMY	Bristol Myers Squibb Co	1,460	$84,125

All Filings in JNJ

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$426,161	1,678	-96.4%	Shares	Sole	2026-08-03
2025-09-30	$8,651,140	46,657	-10.9%	Shares	Sole	2025-11-13
2025-06-30	$8,002,419	52,389	+844.3%	Shares	Sole	2025-07-31
2025-03-31	$920,080	5,548	-42.7%	Shares	Sole	2025-05-07
2024-12-31	$1,400,500	9,684	+3.5%	Shares	Sole	2025-02-19
2024-09-30	$1,517,043	9,361	-57.4%	Shares	Sole	2024-11-13
2024-06-30	$3,212,450	21,979	+16.3%	Shares	Sole	2024-09-17
2024-03-31	$2,988,525	18,892	+1789.2%	Shares	Sole	2024-08-29
2022-12-31	$176,650	1,000	+1036.4%	Shares	Sole	2023-02-14
2021-09-30	$14,212	88	+158.8%	Shares	Sole	2021-11-09
2020-12-31	$5,350	34	—	Shares	Sole	2021-02-05
No filing history on record for this holder in this stock.